AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Authors: Tripp, RA Jones, LP Haynes, LM Zheng, HQ Murphy, PM Anderson, LJ
Citation: Ra. Tripp et al., CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein, NAT IMMUNOL, 2(8), 2001, pp. 732-738
Viral exploitation and subversion of the immune system through chemokine mimicry
Authors: Murphy, PM
Citation: Pm. Murphy, Viral exploitation and subversion of the immune system through chemokine mimicry, NAT IMMUNOL, 2(2), 2001, pp. 116-122
High pressure treatment: applications in cheese manufacture and ripening
Authors: O'Reilly, CE Kelly, AL Murphy, PM Beresford, TP
Citation: Ce. O'Reilly et al., High pressure treatment: applications in cheese manufacture and ripening, TRENDS FOOD, 12(2), 2001, pp. 51-59
Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1
Authors: Hu, JY Le, YY Gong, WH Dunlop, NM Gao, JL Murphy, PM Wang, JM
Citation: Jy. Hu et al., Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1, J LEUK BIOL, 70(1), 2001, pp. 155-161
Cloning, mRNA distribution, and functional expression of an avian counterpart of the chemokine receptor/HIV coreceptor CXCR4
Authors: Liang, TS Hartt, JK Lu, S Martins-Green, M Gao, JL Murphy, PM
Citation: Ts. Liang et al., Cloning, mRNA distribution, and functional expression of an avian counterpart of the chemokine receptor/HIV coreceptor CXCR4, J LEUK BIOL, 69(2), 2001, pp. 297-305
Amyloid beta(42) activates a G-protein-coupled chemoattractant receptor, FPR-Like-1
Authors: Le, YY Gong, WH Tiffany, HL Tumanov, A Nedospasov, S Shen, WP Dunlop, NM Gao, JL Murphy, PM Oppenheim, JJ Wang, JM
Citation: Yy. Le et al., Amyloid beta(42) activates a G-protein-coupled chemoattractant receptor, FPR-Like-1, J NEUROSC, 21(2), 2001, pp. NIL_11-NIL_15
Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5 Delta 32) and normal human lymphoid tissue
Authors: Malkevitch, N McDermott, DH Yi, YJ Grivel, JC Schols, D De Clercq, E Murphy, PM Glushakova, S Collman, RG Margolis, L
Citation: N. Malkevitch et al., Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5 Delta 32) and normal human lymphoid tissue, VIROLOGY, 281(2), 2001, pp. 239-247
Chemokines and the molecular basis of cancer metastasis.
Authors: Murphy, PM
Citation: Pm. Murphy, Chemokines and the molecular basis of cancer metastasis., N ENG J MED, 345(11), 2001, pp. 833-835
The endogenous opioid spinorphin blocks fMet-leu-phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptorsubtype FPR
Authors: Liang, TS Gao, JL Fatemi, O Lavigne, M Leto, TL Murphy, PM
Citation: Ts. Liang et al., The endogenous opioid spinorphin blocks fMet-leu-phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptorsubtype FPR, J IMMUNOL, 167(11), 2001, pp. 6609-6614
Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine via a C-terminal signaling and chemokine production determinant
Authors: Schwarz, M Murphy, PM
Citation: M. Schwarz et Pm. Murphy, Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine via a C-terminal signaling and chemokine production determinant, J IMMUNOL, 167(1), 2001, pp. 505-513
Cutting edge: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1
Authors: Le, YY Yazawa, H Gong, WH Yu, ZX Ferrans, VJ Murphy, PM Wang, JM
Citation: Yy. Le et al., Cutting edge: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1, J IMMUNOL, 166(3), 2001, pp. 1448-1451
Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection
Authors: Khan, IA Murphy, PM Casciotti, L Schwartzman, JD Collins, J Gao, JL Yeaman, GR
Citation: Ia. Khan et al., Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection, J IMMUNOL, 166(3), 2001, pp. 1930-1937
A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression
Authors: Venkatesan, S Petrovic, A Locati, M Kim, YO Weissman, D Murphy, PM
Citation: S. Venkatesan et al., A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression, J BIOL CHEM, 276(43), 2001, pp. 40133-40145
Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain
Authors: Tiffany, HL Lavigne, MC Cui, YH Wang, JM Leto, TL Gao, JL Murphy, PM
Citation: Hl. Tiffany et al., Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain, J BIOL CHEM, 276(26), 2001, pp. 23645-23652
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
Authors: McDermott, DH Halcox, JPJ Schenke, WH Waclawiw, MA Merrell, MN Epstein, N Quyyumi, AA Murphy, PM
Citation: Dh. Mcdermott et al., Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis, CIRCUL RES, 89(5), 2001, pp. 401-407
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Authors: Moatti, D Faure, S Fumeron, F Amara, ME Seknadji, P McDermott, DH Debre, P Aumont, MC Murphy, PM de Prost, D Combadiere, C
Citation: D. Moatti et al., Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease, BLOOD, 97(7), 2001, pp. 1925-1928
Suicidal nonfatal impalement injury of the thorax
Authors: Cartwright, AJ Taams, KO Unsworth-White, MJ Mahmood, N Murphy, PM
Citation: Aj. Cartwright et al., Suicidal nonfatal impalement injury of the thorax, ANN THORAC, 72(4), 2001, pp. 1364-1366
Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics
Authors: Perretti, M Getting, SJ Solito, E Murphy, PM Gao, JL
Citation: M. Perretti et al., Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics, AM J PATH, 158(6), 2001, pp. 1969-1973
Ecological Characteristics of M-paratuberculosis
Authors: Collins, MT Spahr, U Murphy, PM
Citation: Mt. Collins et al., Ecological Characteristics of M-paratuberculosis, BULLETIN OF THE INTERNATIONAL DAIRY FEDERATION NO 362/2001 - MYCOBACTERIUMPARATUBERCULOSIS, 2001, pp. 32-40
Host-related immunomodulators encoded by poxviruses and herpesviruses
Authors: McFadden, G Murphy, PM
Citation: G. Mcfadden et Pm. Murphy, Host-related immunomodulators encoded by poxviruses and herpesviruses, CURR OPIN M, 3(4), 2000, pp. 371-378
Plasmin activity, beta-lactoglobulin denaturation and proteolysis in high pressure treated milk
Authors: Scollard, PG Beresford, TP Needs, EC Murphy, PM Kelly, AL
Citation: Pg. Scollard et al., Plasmin activity, beta-lactoglobulin denaturation and proteolysis in high pressure treated milk, INT DAIRY J, 10(12), 2000, pp. 835-841
Microbiological changes during ripening in two Irish smear-ripened, farmhouse cheeses produced from raw milk
Authors: Maher, MM Murphy, PM
Citation: Mm. Maher et Pm. Murphy, Microbiological changes during ripening in two Irish smear-ripened, farmhouse cheeses produced from raw milk, IRISH J A F, 39(1), 2000, pp. 107-121
Chemokines and their receptors in infectious disease
Authors: McDermott, DH Murphy, PM
Citation: Dh. Mcdermott et Pm. Murphy, Chemokines and their receptors in infectious disease, SPR SEM IMM, 22(4), 2000, pp. 393-415
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy
Authors: O'Brien, TR McDermott, DH Ioannidis, JPA Carrington, M Murphy, PM Havlir, DV Richman, DD
Citation: Tr. O'Brien et al., Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy, AIDS, 14(7), 2000, pp. 821-826
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study
Authors: McDermott, DH Beecroft, MJ Kleeberger, CA Al-Sharif, EM Ollier, WER Zimmerman, PA Boatin, BA Leitman, SF Detels, R Hajeer, AH Murphy, PM
Citation: Dh. Mcdermott et al., Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS, 14(17), 2000, pp. 2671-2678
Risultati: 1-25 | 26-50 | 51-60